Rafferty Asset Management’s Ionis Pharmaceuticals IONS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$5.72M Sell
144,770
-31,478
-18% -$1.24M 0.02% 369
2025
Q1
$5.32M Sell
176,248
-61,089
-26% -$1.84M 0.02% 360
2024
Q4
$8.3M Buy
237,337
+38,578
+19% +$1.35M 0.03% 319
2024
Q3
$7.96M Buy
198,759
+29,903
+18% +$1.2M 0.03% 319
2024
Q2
$8.05M Sell
168,856
-39,613
-19% -$1.89M 0.03% 319
2024
Q1
$9.04M Buy
208,469
+24,073
+13% +$1.04M 0.03% 297
2023
Q4
$9.33M Sell
184,396
-31,575
-15% -$1.6M 0.04% 299
2023
Q3
$9.8M Buy
215,971
+11,583
+6% +$525K 0.06% 230
2023
Q2
$8.39M Buy
204,388
+501
+0.2% +$20.6K 0.05% 253
2023
Q1
$7.29M Sell
203,887
-15,092
-7% -$539K 0.05% 277
2022
Q4
$8.27M Buy
218,979
+67,005
+44% +$2.53M 0.07% 249
2022
Q3
$6.72M Buy
151,974
+32,691
+27% +$1.45M 0.07% 235
2022
Q2
$4.42M Sell
119,283
-59,511
-33% -$2.2M 0.04% 302
2022
Q1
$6.62M Sell
178,794
-10,845
-6% -$402K 0.04% 294
2021
Q4
$5.77M Buy
189,639
+92,902
+96% +$2.83M 0.03% 323
2021
Q3
$3.25M Buy
96,737
+27,965
+41% +$938K 0.02% 432
2021
Q2
$2.74M Buy
68,772
+5,888
+9% +$235K 0.02% 535
2021
Q1
$2.83M Buy
62,884
+42,536
+209% +$1.91M 0.02% 528
2020
Q4
$1.15M Sell
20,348
-17,831
-47% -$1.01M 0.01% 472
2020
Q3
$1.81M Buy
38,179
+21,695
+132% +$1.03M 0.02% 448
2020
Q2
$972K Buy
16,484
+8,990
+120% +$530K 0.01% 556
2020
Q1
$354K Sell
7,494
-54,943
-88% -$2.6M 0.01% 396
2019
Q4
$3.77M Sell
62,437
-35,726
-36% -$2.16M 0.06% 181
2019
Q3
$5.88M Buy
98,163
+18,299
+23% +$1.1M 0.09% 133
2019
Q2
$5.13M Buy
79,864
+9,477
+13% +$609K 0.09% 161
2019
Q1
$5.71M Buy
+70,387
New +$5.71M 0.09% 116